Freiburg, Germany

A Center of Excellence for Cell & Gene Therapy Materials

Sartorius is expanding its presence in Germany with a new research and manufacturing site in the industrial area of Freiburg, a new center of excellence for the development and production of quality‑critical materials such as cytokines and growth factors for cell and gene therapies. This capacity expansion is an important milestone in Sartorius’ global development and manufacturing network. By securing and scaling the availability of critical raw materials , Sartorius helps customers reduce risk, accelerate development, and bring innovative therapies to patients faster.

  • New production and laboratory building with approx. 18,000 m² gross floor area
  • Pre-certified with a DGNB Gold Certification for its sustainable construction including geothermal energy, well water cooling, photovoltaics, and a green facade
  • On-schedule completion following the laying of the foundation stone in 2023: Start of production planned for the end of 2026

Media Release

Sartorius opens new competence center in Freiburg, Germany

May 21, 2026 - The new competence center is dedicated to the development and production of materials for the cell and gene therapy market.

icon-building

Facility Space

18,000 m2

for production, laboratory, and office space

icon-sun

Solar Energy Surface

2,500 m2

of solar installation on site

Product Hub

Products Manufactured On-Site

20+

with a focus on cell culture 

More Information

icon-article

Media Release

September 19, 2023 - Sartorius establishes competence center for manufacturing components for cell and gene therapies in Freiburg

Read Now
icon-magnifier

Product Porfolio

Comprehensive Cell Culture Media, Cell Line, and Buffer Solutions.

Explore the Portfolio

Site Impressions

Member of the Executive Board and Head of the Bioprocess Solutions Division

Dr. René Fáber

Cell and gene therapies offer patients hope for curing diseases that were previously considered untreatable. Cytokines, growth factors, and cell culture media are essential for the development and manufacture of these innovative therapies. As a key site in our global network for these critical materials, Freiburg serves a dynamic market with high requirements for speed, scalability, and process reliability. By significantly expanding our capacities, we can respond much more flexibly to demand from our biopharma customers and support them even better in bringing cell and gene therapies to patients faster and more efficiently.

Cell Culture Media

A Winning Culture Starts Here

Cell Culture Media Solutions For Your Cell-, Viral-, and Protein-Based Therapies​​

Choose a winning culture for your therapy development. At Sartorius, we offer a wide range of media, raw materials, and services to meet your cell culture needs. Backed by a global manufacturing network, we provide what’s vital to your cells and your success - from screening to commercial production.

  • Find the right media, raw materials, and supporting services
  • Transition to GMP with compliant media and reagents
  • Scale seamlessly with flexible formats
  • Work with our dedicated technical and regulatory experts
  • Get consistent quality from our global manufacturing network
growth factors and cytokines

On-site Production of Cytokine & Growth Factors

Sartorius offers an extensive portfolio of high-quality, recombinant, animal-free and carrier-free growth factors and cytokines.

Learn More

Interested In Our Product Portfolio?

Consult Our Experts

Consult Our Experts